# A Bioequivalence Study of TAK-536 Pediatric Formulation

> **NCT02401464** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 52 (actual)

## Conditions studied

- Japanese Healthy Adult Males

## Interventions

- **DRUG:** TAK-536 Tablet
- **DRUG:** TAK-536 Dry Syrup Formulation
- **DRUG:** TAK-536 Ganule Formulation

## Key facts

- **NCT ID:** NCT02401464
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2016-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02401464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02401464, "A Bioequivalence Study of TAK-536 Pediatric Formulation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02401464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*